{'fraction_non_alphanumeric': 0.012106537530266344, 'fraction_numerical': 0.0, 'mean_word_length': 5.361538461538461, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Office‐based treatment of vocal fold scarring with transcutaneous chordal steroid injections

Vocal fold scarring still remains a therapeutic challenge, with the most problematic issue being the histologic changes that are primarily responsible for altering the viscoelasticity of the vocal fold mucosa. Optimal treatment for vocal fold scarring has not yet been established. Local administrations of steroid directly into the larynx have been reported. Corticosteroid is one of the most potent inhibitors of inflammation in addition to promoting wound repair. Office-based steroid injections of the vocal folds are not popular as a result of the perception that technically it is difficult with questionable benefit. The aim of this study was to analyze the effects of office-based steroid injections for vocal fold scarring.